SPT Labtech
Private Company
Total funding raised: $85M
Overview
SPT Labtech is a leading provider of specialized lab automation equipment, serving the genomics, drug discovery, and structural biology markets. Founded in 2005 and headquartered in Cambridge, UK, the company has built a portfolio of high-precision instruments like mosquito, dragonfly, and firefly for liquid handling, alongside sample management systems such as comPOUND and arktic. It operates as a private, revenue-generating business, collaborating with major industry partners to co-develop integrated workflows that increase laboratory productivity and data quality.
Technology Platform
Portfolio of specialized lab automation platforms for liquid handling (mosquito, dragonfly, firefly), sample preparation (chameleon for cryo-EM), and sample management (comPOUND, arktic). Focus on precision, miniaturization, and workflow integration.
Funding History
3Opportunities
Risk Factors
Competitive Landscape
SPT Labtech competes in a fragmented but competitive market. It faces large, broad-based automation providers like Tecan, PerkinElmer, and Agilent, as well as specialized players in areas like liquid handling (e.g., Formulatrix) and sample management (e.g., Brooks Life Sciences). Its differentiation lies in high-precision, application-focused platforms and a strategy of deep collaboration with workflow leaders.